New data from Ahmed et al. show that discharge prescriptions for renin–angiotensin–aldosterone inhibitor therapy are associated with a significant reduction in all-cause mortality in elderly patients with diastolic heart failure and chronic kidney disease (CKD). These observational data support the case for prospective studies of RAAS blockade in patients with CKD and diastolic heart failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ahmed, A. et al. Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am. J. Med. 126, 150–161 (2013).
Tonelli, M. et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380, 807–814 (2012).
Rakhit, D. J. et al. Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Am. Heart J. 153, 656–664 (2007).
Pecoits-Filho, R. et al. Diastolic heart failure in dialysis patients: Mechanisms, diagnostic approach and treatment. Semin. Dial. 25, 35–41 (2012).
Liu, S. S., Monti, J., Kargbo, H. M., Athar, M. W. & Parakh, K. Frontiers of therapy for patients with heart failure. Am. J. Med. 126, 6–12 (2013).
Ahmed, A. et al. Renin–angiotensin inhibition in systolic heart failure and chronic kidney disease. Am. J. Med. 125, 399–410 (2012).
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practical Guideline for the management of blood pressure in chronic kidney disease. Kidney Int. Suppl. 2, 337–414 (2012).
Lambers Heerspink, H. J. et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 82, 330–337 (2012).
Vegter, S. et al. Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23, 165–173 (2012).
Holtkamp, F. A. et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int. 80, 282–287 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Franssen, C., Navis, G. RAAS blockade and diastolic heart failure in chronic kidney disease. Nat Rev Nephrol 9, 190–192 (2013). https://doi.org/10.1038/nrneph.2013.39
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.39
This article is cited by
-
Echocardiographic manifestations in end-stage renal disease
Heart Failure Reviews (2023)
-
Evolving concepts in the pathogenesis of uraemic cardiomyopathy
Nature Reviews Nephrology (2019)